The care of patients with subarachnoid hemorrhage (SAH) has improved dramatically over the last decades. These gains are the result of improved microsurgical, endovascular, and medical management techniques. This intensive management subjects patients to multiple radiographic studies and thus increased radiation exposure. As greater understanding of the risks of radiation exposure develops, physicians must be better equipped to balance the need for optimal SAH management with the minimization of patient exposure to radiation from imaging studies. The goal in the current study was to determine if there is an opportunity for a reduction in radiation dose without a change in the quality of treatment in patients with SAH.
A retrospective chart review of all patients hospitalized for SAH at the Brigham and Women's Hospital in the period from January 1, 2009, to August 31, 2010, was performed. The authors calculated cumulative and imaging study–specific radiation doses, determined the time of day that imaging studies were performed, and surveyed neurosurgeons regarding issues surrounding imaging-related radiation exposure.
The data for 77 patients were analyzed. The mean cumulative radiation dose during hospitalization was 2.76 Gy per patient (range 0.46–8.32 Gy). The mean radiation exposure from each CT, CT angiography (CTA), and angiography study was 0.08, 0.29, and 0.77 Gy (ranges 0.02–0.40, 0.15–0.99, and 0.11–4.36 Gy, respectively). Subgroup analysis of the top quartile of patients in terms of total radiation dose revealed a mean cumulative radiation dose of 4.78 Gy (range 3.42–8.32 Gy), mean cumulative number of CT and CTA scans of 14, and mean CT or CTA scan per day of 0.5 (maximum 0.8). Seventeen percent of the noncontrast head CT studies were performed just prior to morning rounds, more than double the 8% expected rate at random. Thirty-four percent of the repeat noncontrast head CTs did not show any change between scans, as documented on radiology reports. When surveyed, a majority of neurosurgeons incorrectly estimated the radiation dose typically received from CT, CTA, and angiography studies, and 65% asserted that radiation exposure is “not important” or only “somewhat important” when considering whether to order an imaging study.
Study findings suggested that patients with SAH have significant imaging-related exposure to radiation. The authors believe it is possible to continue the current improved outcomes in SAH with a significant reduction in radiation exposure from imaging studies. This analysis highlights the significance of accurate assessment of radiation exposure as a quality improvement target.
Abbreviations used in this paper:CAK = cumulative air kerma; CTA = CT angiography; CTDIvol = volume CT dose index; SAH = subarachnoid hemorrhage.
BedersonJBConnollyESJrBatjerHHDaceyRGDionJEDiringerMN: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke40:994–10252009
ChangELWefelJSHessKRAllenPKLangFFKornguthDG: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol10:1037–10442009
GonzalezNRBoscardinWJGlennTVinuelaFMartinNA: Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg107:1101–11122007
HaleyECJrKassellNFTornerJC: A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg78:548–5531993
Le PéchouxCLaplancheAFaivre-FinnCCiuleanuTWandersRLerougeD: Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol22:1154–11632011
Le RouxPDElliottJPDowneyLNewellDWGradyMSMaybergMR: Improved outcome after rupture of anterior circulation aneurysms: a retrospective 10-year review of 224 good-grade patients. J Neurosurg83:394–4021995
LoftusMLMinkowitzSTsiourisAJMinRJSanelliPC: Utilization guidelines for reducing radiation exposure in the evaluation of aneurysmal subarachnoid hemorrhage: a practice quality improvement project. AJR Am J Roentgenol195:176–1802010
SantillanAKnopmanJZinkWPatsalidesAGobinYP: Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery59:95–1012011
SeidlingHMPhansalkarSSegerDLPaternoMDShaykevichSHaefeliWE: Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc18:479–4842011
US Food and Drug Administration: White Paper: Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging(http://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/ucm199994.htm) [Accessed March 22 2013]
WhitePMGilmourJNWeirNWInnesBSellarRJ: AngioCT in the management of neurointerventional patients: a prospective, consecutive series with associated dosimetry and resolution data. Neuroradiology50:321–3302008